Charcot–Marie–Tooth Disease Type 2B5 (CMT2B5)

Charcot–Marie–Tooth disease type 2B5 (CMT2B5) is a very rare inherited nerve disease where the long nerves to the feet, legs, hands, and arms slowly become weak and damaged. Doctors call it an axonal hereditary motor and sensory neuropathy, which means the main problem is in the axon (the long “wire” part) of the nerve, and it affects both movement (motor) and feeling (sensory).Orpha.net+1

Charcot-Marie-Tooth disease type 2B5 (CMT2B5) is a very rare form of axonal Charcot-Marie-Tooth disease. “Axonal” means the long wires of the nerves (axons) are mainly damaged, not the myelin coating. It is caused by changes in genes that control how peripheral nerves work, often affecting both movement and feeling in the feet, legs, hands, and arms. CMT2B5 is usually slowly progressive over many years and can lead to weak ankles, foot deformity (often high arches and curled toes), balance problems, falls, and later weakness in the hands. There is no cure yet and no drug that specifically reverses this gene problem. Current care for all CMT2 types focuses on rehabilitation, orthotics (braces and special shoes), pain control, and selected surgery, while research is exploring gene therapy and regenerative approaches. Mayo Clinic+3Muscular Dystrophy Association+3Charcot-Marie-Tooth Association+3

In CMT2B5, symptoms usually begin in infancy or very early childhood. Children often have floppy muscles (hypotonia), delayed milestones such as sitting or walking, and slowly progressive weakness and shrinking (atrophy) of the muscles in the feet and legs first, and later in the hands and arms. Sensation to touch, pain, temperature, and vibration is reduced in the feet and hands, because the sensory nerves are also damaged.GARD Information Center+2e2g.stanford.edu+2

CMT2B5 is caused by recessive mutations in the NEFL gene, which encodes the light chain of neurofilament, a key structural protein inside axons. When NEFL does not work properly, the axon cannot keep its normal size and structure, and nerve signals travel poorly. This leads to early-onset, severe, length-dependent nerve damage and disability.PMC+2PubMed+2

Other names

Doctors and researchers use several other names for the same condition. These names are useful when searching medical articles or genetic reports:

• Autosomal recessive Charcot–Marie–Tooth disease type 2B5 (AR-CMT2B5) – shows that the disease is inherited in an autosomal recessive way.NCBI+1

• Severe early-onset axonal neuropathy due to NEFL deficiency – stresses that symptoms start early in life and that the problem is lack of normal NEFL function in axons.NCBI+1

• Severe early-onset axonal neuropathy due to light neurofilament subunit deficiency – another way to say that the light neurofilament subunit (NEFL protein) is missing or not working.monarchinitiative.org+1

• Hereditary motor and sensory neuropathy due to NEFL mutation (HMSN due to NEFL) – uses the older term HMSN instead of CMT.neuromuscular.wustl.edu+2Charcot-Marie-Tooth Disease+2

All of these terms describe the same clinical picture: a genetic, early-onset, axonal peripheral neuropathy caused by pathogenic changes in NEFL.inc.rarediseasesnetwork.org+1

Types

There is only one genetic subtype officially called CMT2B5, and it is linked to recessive mutations in the NEFL gene. However, because the age when symptoms start and how severe they are can vary slightly between families and individuals, clinicians sometimes describe clinical patterns or “types” based on onset and severity, not different genes.PMC+2inc.rarediseasesnetwork.org+2

Common clinical “types” that doctors may informally describe are:

1. Typical infantile-onset CMT2B5 – onset before age 3, with delayed walking, floppy muscles, and early foot deformities; this is the classical description in most reports.GARD Information Center+1

2. Very severe early-infantile type – symptoms from the first year of life, with marked hypotonia, very slow motor development, and early profound weakness and sensory loss.PMC+1

3. Childhood-onset but slightly milder course – some NEFL-related neuropathies show onset later in childhood with slower progression, although these are still serious and disabling over time.ScienceDirect+1

These “types” help doctors describe patients, but current evidence still supports one main genetic entity: NEFL-related, autosomal recessive axonal CMT2B5.PMC+1

Causes and contributing mechanisms

CMT2B5 has one main root cause – a mutation in the NEFL gene – but many biological mechanisms and factors shape how the disease appears.

1. Pathogenic NEFL gene mutations – CMT2B5 is caused by harmful changes (such as nonsense or frameshift mutations) in both copies of the NEFL gene. These mutations lead to loss of normal neurofilament light protein and severe, early-onset axonal neuropathy.PMC+2PubMed+2

2. Autosomal recessive inheritance from carrier parents – parents usually carry one faulty NEFL gene each but are healthy. When a child inherits both faulty copies, they develop CMT2B5. Autosomal recessive inheritance explains why several affected siblings may appear in the same family.NCBI+2inc.rarediseasesnetwork.org+2

3. Loss of neurofilament light chain function – NEFL encodes the light chain of neurofilaments, which are key structural proteins inside axons that maintain their diameter and support fast conduction. When NEFL is missing or nonfunctional, axons become thin and fragile.PubMed+2inc.rarediseasesnetwork.org+2

4. Disrupted axonal cytoskeleton and transport – neurofilaments help stabilize microtubules and support the transport of nutrients and organelles along the axon. NEFL mutations disturb this internal “railway,” leading to axonal degeneration, especially in long nerves to the feet and hands.PMC+2Radiological Society of North America+2

5. Length-dependent vulnerability of long nerves – the longest motor and sensory axons, especially those to the feet, are most sensitive to NEFL dysfunction. This length-dependent effect explains why weakness and sensory loss start in the feet and ankles and later move upward.Wikipedia+2Wikipedia+2

6. Progressive axonal degeneration – over time, damaged axons degenerate and may be lost. Nerve conduction studies in CMT2 and NEFL-related neuropathy show reduced amplitudes, reflecting axonal loss rather than primary demyelination.PMC+2ScienceDirect+2

7. Secondary changes in myelin – although CMT2B5 is mainly axonal, chronic axonal damage can secondarily affect myelin structure, further slowing conduction and worsening weakness and sensory impairment.neuromuscular.wustl.edu+1

8. Chronic denervation of distal muscles – when motor axons degenerate, the muscles they supply lose nerve input and gradually shrink (atrophy). This is seen clinically as thin calves and weak intrinsic foot and hand muscles.Wikipedia+2frontiersin.org+2

9. Muscle imbalance around the foot and ankle – some muscles become weaker than others, creating imbalance that pulls the foot into a high-arched cavovarus shape with claw toes. This deformity is typical in many CMT types.PMC+2frontiersin.org+2

10. Joint contractures from long-standing weakness – over years, tight tendons and unbalanced muscle pull can fix joints in abnormal positions, leading to contractures at the ankles and toes, which further limit movement.PMC+2ScienceDirect+2

11. Distal sensory nerve damage – sensory axons also degenerate, causing loss of pain, temperature, light touch, and position sense. This increases the risk of unnoticed injuries, ulcers, and balance problems.GARD Information Center+2inc.rarediseasesnetwork.org+2

12. Delayed motor development due to early nerve dysfunction – because axonal damage starts very early, infants may sit, stand, or walk later than expected. Hypotonia and poor nerve supply make it harder to gain normal strength and coordination.GARD Information Center+2PMC+2

13. Possible genetic modifiers – research on NEFL-related neuropathies suggests that other genes may modify the severity and exact phenotype, which could explain some variability between families and individuals with similar NEFL mutations.ScienceDirect+1

14. General genetic background and consanguinity – in some families, consanguinity (parents who are related) increases the chance that both parents carry the same NEFL mutation, raising the risk of autosomal recessive diseases like CMT2B5.National Organization for Rare Disorders+1

15. Metabolic stress in vulnerable neurons – long peripheral neurons have high energy needs, and axonal damage plus neurofilament defects may increase metabolic and oxidative stress, making them more likely to degenerate over time. This is a general mechanism seen in many axonal neuropathies.Radiological Society of North America+1

16. Reduced capacity for axonal regeneration – after axonal injury, regeneration may be incomplete in CMT because the underlying genetic problem continues. This contributes to progressive, rather than reversible, weakness and sensory loss.UCL Discovery+1

17. Superimposed acquired neuropathy (e.g., diabetes) – if a person with CMT2B5 later develops another cause of peripheral nerve damage, such as diabetes or severe vitamin deficiency, their neuropathy can become much worse, even though the genetic disease remains the primary cause.Wikipedia+1

18. Neurotoxic medications or toxins – drugs that can damage peripheral nerves (for example certain chemotherapy agents) or chronic exposure to toxins may further injure already fragile axons in someone with CMT2B5.Wikipedia+1

19. Poor nutrition and physical inactivity – lack of good nutrition and low physical activity do not cause the genetic defect, but they may weaken muscles, worsen fatigue, and reduce the ability to compensate for neuropathy.Physiopedia+1

20. Recurrent mechanical stress and falls – repeated ankle sprains, falls, and abnormal loading of the feet due to cavovarus deformity can add secondary joint and soft tissue damage on top of the primary neuropathy.frontiersin.org+2ScienceDirect+2

Symptoms and signs

People with CMT2B5 show many features that are typical of axonal CMT, but they tend to start earlier and be more severe.

1. Distal leg weakness – weakness starts in the muscles that move the ankles and toes, especially those that lift the foot. This makes it hard to dorsiflex the foot against gravity and is often the first clear symptom.GARD Information Center+2inc.rarediseasesnetwork.org+2

2. Foot drop and high-stepping gait – because ankle dorsiflexion is weak, the toes may drag on the ground, causing foot drop. To compensate, people lift their knees higher when walking, creating a “steppage” gait.Wikipedia+2frontiersin.org+2

3. Muscle atrophy of lower legs (“inverted champagne bottle” shape) – over time, the calf muscles shrink while the thighs remain relatively preserved. This leads to thin lower legs with normal-sized thighs.GARD Information Center+2Physiopedia+2

4. High-arched feet (pes cavus) and cavovarus deformity – the arch of the foot becomes very high and the heel may turn inward. This cavovarus deformity is very common in CMT and becomes more severe as the disease progresses.PMC+2ResearchGate+2

5. Claw or hammer toes – the small muscles in the feet become weak, and the long toe tendons pull the toes into bent positions, causing clawing or hammer toes, which can make shoe-wearing painful.PMC+2ResearchGate+2

6. Distal hand weakness and loss of fine motor skills – as neuropathy progresses, the small muscles of the hands weaken. Tasks such as buttoning clothes, tying shoelaces, or writing may become difficult.GARD Information Center+2inc.rarediseasesnetwork.org+2

7. Reduced or absent tendon reflexes – deep tendon reflexes, especially at the ankles and knees, are usually decreased or absent because the peripheral motor and sensory arcs are disrupted.PMC+2Orthobullets+2

8. Distal sensory loss (all modalities) – people often have reduced ability to feel vibration, joint position, light touch, pain, and temperature in their feet and later in their hands, because sensory axons are damaged.GARD Information Center+2inc.rarediseasesnetwork.org+2

9. Balance problems and unsteady walking – loss of position sense in the feet and muscle weakness together cause poor balance. Walking in the dark or on uneven ground can be especially challenging and may lead to falls.frontiersin.org+2PMC+2

10. Delayed motor milestones in infancy – many children with CMT2B5 sit, stand, and walk later than expected. They may seem “floppy” (hypotonic) and tires easily.GARD Information Center+2PMC+2

11. Generalized hypotonia (low muscle tone) – especially early in life, muscles feel soft and less resistant to passive movement, reflecting reduced motor unit activation.GARD Information Center+2PMC+2

12. Fatigue and reduced endurance – walking long distances, climbing stairs, or standing for a long time can be very tiring, because weakened muscles must work harder and compensate for poor nerve signals.science.gov+2frontiersin.org+2

13. Foot pain, calluses, and ankle instability – abnormal foot shape and weakness can cause chronic pain, frequent sprains, calluses from uneven pressure, and difficulty finding comfortable shoes.PMC+2ScienceDirect+2

14. Neuropathic discomfort (tingling or burning) – some people with CMT experience tingling, “pins and needles,” or burning sensations in their feet and hands because of damaged sensory fibers, although pain is often milder than in some other neuropathies.science.gov+2Wikipedia+2

15. Slowly progressive course – symptoms generally worsen slowly over years. Many children grow into adults with significant disability but may still remain ambulatory with supports, though the severity in CMT2B5 can be high.GARD Information Center+2inc.rarediseasesnetwork.org+2

Diagnostic tests

Diagnosis of CMT2B5 combines clinical examination, electrodiagnostic tests, and genetic testing, with other tests used to rule out different causes of neuropathy or to understand complications.PMC+2Charcot-Marie-Tooth Association+2

Physical examination

1. Comprehensive neurological examination – the neurologist checks muscle strength, tone, reflexes, coordination, and sensation in all four limbs. In CMT2B5, the exam usually shows distal weakness, reduced or absent reflexes, and distal sensory loss, especially in the legs.GARD Information Center+2Orthobullets+2

2. Gait and posture assessment – the doctor watches how the person walks, turns, and stands on heels or toes. A high-stepping gait, difficulty heel-walking, and ankle instability suggest distal weakness and foot drop typical of CMT.frontiersin.org+2Charcot-Marie-Tooth Disease+2

3. Inspection of feet, legs, and hands – clinicians look for pes cavus, cavovarus deformity, claw toes, thin calves, and hand muscle wasting. These visible changes help distinguish inherited neuropathy from other causes of weakness.PMC+2Radiological Society of North America+2

4. Developmental and motor milestone evaluation (in children) – in infants and young children, doctors ask about the age of sitting, standing, and walking, and observe gross motor skills. Delayed milestones and hypotonia in combination with neuropathic signs raise suspicion for early-onset CMT like CMT2B5.GARD Information Center+2PMC+2

Manual and bedside tests

5. Manual muscle testing (MRC scale) – each muscle group is graded by the examiner on a 0–5 scale. In CMT2B5, ankle dorsiflexors and intrinsic foot and hand muscles often show the lowest scores, confirming distal pattern weakness.frontiersin.org+2Radiological Society of North America+2

6. Deep tendon reflex testing with a reflex hammer – the clinician taps the tendons at the ankle, knee, elbow, and wrist. In inherited axonal neuropathies, reflexes are reduced or absent, which supports peripheral nerve involvement.PMC+2Orthobullets+2

7. Sensory bedside testing – using cotton, a pin, tuning fork, and simple tools, the doctor checks light touch, pinprick, vibration, and joint position sense. Distal loss in a “stocking-glove” pattern suggests length-dependent sensory axon damage.GARD Information Center+2Physiopedia+2

8. Balance and Romberg testing – the patient stands with feet together, first with eyes open and then closed. Increased sway or falls when eyes are closed suggest impaired proprioception from sensory neuropathy.frontiersin.org+2Physiopedia+2

Laboratory and pathological tests

9. Genetic testing panel for CMT – a blood sample is used to analyze many CMT-related genes at once. When CMT2B5 is suspected, the panel should include NEFL, and finding biallelic pathogenic NEFL variants confirms the diagnosis.Mayo Clinic+2Charcot-Marie-Tooth Association+2

10. Targeted NEFL gene sequencing or exome sequencing – if a broad panel is negative or if NEFL is strongly suspected, more detailed sequencing (including exome or genome sequencing) may detect rare or novel NEFL mutations responsible for early-onset axonal neuropathy.PMC+2PubMed+2

11. Nerve biopsy with histology and immunostaining – in uncertain cases, a small piece of sural nerve may be removed and examined under the microscope. In axonal CMT, biopsy shows loss of large myelinated fibers and axonal degeneration; in NEFL-related disease, neurofilament abnormalities may be observed. Biopsy is now used less often because genetic testing is widely available.PMC+2Muscular Dystrophy Association+2

12. Blood tests to exclude other causes of neuropathy – tests for blood sugar, vitamin B12, thyroid function, autoimmune markers, and other metabolic or inflammatory causes help ensure that symptoms are not primarily due to a treatable acquired neuropathy.Wikipedia+2Cleveland Clinic+2

Electrodiagnostic tests

13. Nerve conduction studies (NCS) – electrodes on the skin deliver small electrical pulses to nerves and record responses. In CMT2B5, motor and sensory responses are often low in amplitude, reflecting axon loss, with conduction velocities that may be only mildly reduced, fitting an axonal neuropathy.PMC+2nhs.uk+2

14. Electromyography (EMG) – a thin needle electrode is inserted into muscles to record electrical activity. EMG in CMT shows signs of chronic denervation and reinnervation, confirming a neurogenic, not primary muscle, disorder.Muscular Dystrophy Association+2Cleveland Clinic+2

15. Somatosensory evoked potentials (SSEPs) – in some centers, SSEPs are used to measure how sensory signals from limbs travel to the brain. Delayed or absent responses support significant sensory pathway involvement in severe early-onset axonal neuropathies.Neupsy Key+2UCL Discovery+2

16. Autonomic function testing (when indicated) – tests such as heart rate variability or quantitative sudomotor testing may be used if there is suspicion of autonomic involvement. They are not specific for CMT2B5 but can help document broader peripheral nerve dysfunction.Cleveland Clinic+2UCL Discovery+2

Imaging tests

17. Foot and ankle X-rays – plain radiographs show the bony structure of the foot, degree of cavus or cavovarus deformity, and any associated joint changes. This is important for planning orthotic devices or surgical correction.PMC+2Radiological Society of North America+2

18. Spine and lower limb X-rays or MRI – these imaging tests help detect scoliosis, hip or knee deformities, or other orthopedic complications that may arise from long-standing muscle imbalance and neuropathy.Radiological Society of North America+2Orthobullets+2

19. Muscle MRI or ultrasound – imaging of muscles can show patterns of atrophy and fatty replacement that are typical for hereditary neuropathies, helping to distinguish CMT from primary muscle diseases.Radiological Society of North America+2Cleveland Clinic+2

20. Peripheral nerve ultrasound or MRI neurography – high-resolution imaging of peripheral nerves can reveal nerve thinning or structural changes in inherited axonal neuropathies and may help differentiate CMT from inflammatory neuropathies that often show nerve enlargement.Radiological Society of North America+2ScienceDirect+2

Non-pharmacological treatments

1. Individualized physiotherapy program
   A long-term physiotherapy plan is one of the most important treatments for CMT2B5. A physical therapist teaches safe exercises that keep muscles as strong as possible and joints moving well. The therapist often combines stretching, strengthening, balance work, and walking practice. The goal is not to “cure” the nerve damage, but to slow loss of function, reduce stiffness, and help you move more confidently in daily life. nhs.uk+2Physiopedia+2

2. Daily stretching and range-of-motion exercises
   Gentle stretching of ankles, knees, hips, fingers, and wrists helps keep joints flexible and prevents contractures (permanent joint stiffness). For CMT2B5, the ankles and calves are often tight because of muscle imbalance. A therapist may teach simple stretches you can do sitting or lying in bed. Doing these every day can reduce pain, make walking easier, and delay fixed deformities in the feet and hands.

3. Targeted strength training for weak muscles
   Strength training for CMT2B5 focuses on low resistance and high repetition to keep muscles active without overworking them. The therapist usually targets the muscles that lift the feet and toes, stabilize the ankles, and control the hands. Light bands, body weight, or water exercises are often used. The goal is to support daily activities like walking, climbing stairs, and using your hands, not to build large muscles.

4. Balance and proprioception training
   Because the sensory nerves are affected, many people with CMT2B5 feel unsteady, especially in the dark or on uneven ground. Balance training uses tools like balance boards, foam pads, and simple standing tasks to help your body learn to keep upright using vision and remaining sensation. Practicing safe balance activities with supervision can reduce falls and increase confidence.

5. Gait training and walking practice
   A physiotherapist analyzes how you walk and then teaches strategies to improve your gait. For example, they may coach you to lift your knees higher or slow down to place your feet more carefully. They may introduce treadmill walking with support or over-ground walking with cues. The aim is to make your walking pattern safer, more energy-efficient, and less painful.

6. Occupational therapy for hand and daily-living skills
   Occupational therapists help people with CMT2B5 adapt to hand weakness, numbness, and fatigue. They can teach joint protection techniques, recommend hand exercises, and suggest assistive devices such as built-up pens, button hooks, and special grips. They also help you adapt tasks like writing, cooking, dressing, and using computers so you can stay independent at home, school, or work.

7. Ankle-foot orthoses (AFOs) and leg braces
   Many people with CMT use AFOs, which are light braces worn inside or around the shoes to support weak ankles and lift the toes that tend to drop. These braces can reduce tripping, improve walking speed, and decrease fatigue. Custom-made AFOs are often recommended by neurologists and orthotists after a detailed walking assessment. Charcot-Marie-Tooth Association+1

8. Custom shoes and insoles
   Because CMT2B5 can cause high-arched feet and clawed toes, regular shoes may not fit well. Custom shoes and soft insoles can spread pressure more evenly, prevent calluses and ulcers, and make it more comfortable to walk longer distances. A podiatrist or orthotist helps choose the right shoe shape and cushioning materials.

9. Assistive walking devices (cane, crutch, walker)
   When balance and strength worsen, a cane or walker can make walking much safer. These devices give extra support, reduce the fear of falling, and allow people with CMT2B5 to keep moving instead of avoiding activity. A therapist teaches how to use the device correctly so it helps rather than trips you.

10. Specialist podiatry and foot care
    Regular foot care is crucial in CMT2B5 because numbness can hide small injuries. A podiatrist trims nails, treats calluses and corns, and watches for early signs of pressure sores or deformity. They can advise on socks, footwear, and protective padding. Early treatment of small problems can prevent infections and more serious complications.

11. Home modifications and fall-prevention strategies
    Simple changes at home can greatly reduce fall risk. Removing loose rugs, using grab bars in the bathroom, adding night lights, and keeping frequently used items within easy reach all help. An occupational therapist can visit the home (or review photos/videos) to suggest practical, low-cost safety improvements.

12. Energy-conservation and fatigue management
    Fatigue is common in CMT2B5 because muscles work harder to compensate for nerve damage. Therapists teach pacing strategies, such as planning rest breaks, sitting for tasks when possible, and using wheeled carts or backpacks instead of carrying heavy loads. Learning to manage energy well allows people to participate more fully in important activities.

13. Respiratory physiotherapy (when needed)
    A small number of people with GDAP1-related CMT can develop breathing or diaphragm weakness. In these cases, respiratory physiotherapy may include breathing exercises, cough-assist devices, and training in safe positions for sleep. The goal is to maintain lung function, reduce infections, and support good oxygen levels. ScienceDirect

14. Speech and voice therapy (for vocal-cord involvement)
    Some GDAP1 mutations can affect nerves supplying the vocal cords, leading to hoarseness or weak voice. A speech-language therapist can teach breathing and voice exercises, safe swallowing techniques, and ways to project the voice without straining. This therapy can improve communication and reduce the risk of choking. ScienceDirect

15. Psychological counseling and mental-health support
    Living with a lifelong, inherited condition can cause sadness, anxiety, or frustration. Psychological counseling, cognitive-behavioral therapy, and support groups give a safe space to talk about fears and stress. Learning coping skills and building resilience can improve quality of life as much as physical treatments.

16. Genetic counseling for patient and family
    Because CMT2B5 is genetic, families often have questions about inheritance, testing, and future pregnancies. A genetic counselor explains the pattern of inheritance, the chance that children may be affected, and options for testing. They also help families understand research developments and consider participation in clinical trials. PubMed+1

17. Ergonomic adjustments at school or work
    Ergonomic chairs, adjustable desks, footrests, and adapted keyboards can reduce pain and fatigue in people with CMT2B5. Occupational health teams can help change tasks, allow flexible schedules, or provide remote-work options. These changes help people stay productive and protect their joints and nerves from extra strain.

18. Regular structured exercise program (aerobic and low-impact)
    Low-impact activities such as swimming, cycling on a stationary bike, or gentle walking can maintain cardiovascular fitness without over-loading weak muscles and joints. A doctor or therapist can help set safe exercise limits. Regular activity also supports mood, sleep, and general health.

19. Healthy weight and lifestyle coaching
    Extra body weight increases load on weak muscles and unstable joints, making walking harder and pain worse. Nutrition and lifestyle coaching can help someone with CMT2B5 maintain a healthy weight with balanced food, good sleep, and stress-management practices.

20. Patient education and peer-support groups
    Learning about CMT2B5 helps people recognize symptoms early, avoid harmful activities, and take part in shared decision-making with doctors. Peer-support groups, in person or online, allow people to share tips, learn about assistive technologies, and feel less alone. CMT organizations also share information about new research and clinical trials. Charcot-Marie-Tooth Association+1

---

Drug treatments for Charcot-Marie-Tooth disease type 2B5

There are no medicines currently approved specifically to cure or slow CMT2B5, but several FDA-approved drugs for neuropathic pain and related symptoms are often used off-label in CMT based on their proven effect in other nerve pain conditions. Any use must follow official prescribing information (often from accessdata.fda.gov) and the advice of a neurologist. FDA Access Data+4PMC+4FDA Access Data+4

For each medicine below, think of the “dose” as a range guided by the label and adjusted by the doctor; exact numbers depend on age, kidney function, other drugs, and side-effects.

1. Gabapentin (Neurontin, Gralise – anti-seizure / neuropathic pain drug)
   Gabapentin is an anti-seizure medicine that is also FDA-approved for neuropathic pain such as postherpetic neuralgia. Labels describe starting at a low dose and gradually increasing in divided doses across the day until pain relief or side effects appear. In CMT2B5 it is often used off-label to ease burning, shooting, or tingling pain in the feet and hands. Its mechanism involves binding to specific calcium-channel subunits in nerve cells to reduce abnormal firing. Common side effects include dizziness, sleepiness, and swelling of the legs, so doctors increase the dose slowly and monitor carefully. FDA Access Data+4FDA Access Data+4FDA Access Data+4

2. Pregabalin (Lyrica – anti-seizure / neuropathic pain drug)
   Pregabalin is closely related to gabapentin and is FDA-approved for several neuropathic pain conditions. For CMT2B5, it may be prescribed off-label when nerve pain is severe or not controlled by other drugs. The dose usually starts low and is increased gradually, typically taken two or three times a day. Pregabalin reduces the release of excitatory neurotransmitters by binding to calcium-channel subunits, which calms overactive pain pathways. Side effects can include dizziness, drowsiness, weight gain, and swelling, so it must be used with caution in people who are already unsteady.

3. Duloxetine (Cymbalta – serotonin–norepinephrine reuptake inhibitor)
   Duloxetine is approved for diabetic peripheral neuropathic pain and chronic musculoskeletal pain. In CMT2B5 it can be used off-label to manage similar nerve pain symptoms. It works by increasing serotonin and norepinephrine levels in the spinal cord, which strengthens the brain’s own pain-blocking pathways. It is usually taken once daily. Side effects may include nausea, dry mouth, sleep problems, and increased sweating. Because it is an antidepressant, it may also help with low mood, but it must be monitored for mood changes.

4. Amitriptyline (tricyclic antidepressant)
   Amitriptyline is a tricyclic antidepressant often used at lower doses to treat nerve pain. In CMT2B5 it may be taken at night to reduce burning pain and help with sleep. It blocks reuptake of serotonin and norepinephrine, and also affects sodium channels, which dampens nerve excitability. Side effects commonly include dry mouth, constipation, blurred vision, and drowsiness. It is not suitable for people with certain heart rhythm problems, so doctors usually perform checks before starting.

5. Nortriptyline (tricyclic antidepressant)
   Nortriptyline is similar to amitriptyline but tends to cause slightly fewer sedating and anticholinergic side effects. It can be used for neuropathic pain in conditions like CMT2B5 when other options fail or are not tolerated. Low doses are started, and the doctor adjusts slowly based on pain relief and side effects. It shares a similar mechanism, strengthening descending pain-control pathways and stabilizing nerve membranes.

6. Carbamazepine (anti-seizure drug used for neuropathic pain)
   Carbamazepine is approved for trigeminal neuralgia and epilepsy and can be used off-label for sharp, electric-shock-like pains in neuropathies. It works mainly by blocking voltage-gated sodium channels in nerve membranes, which reduces rapid firing of pain fibers. In CMT2B5, it may help selected patients with painful spasms or shocks, but it has many possible side effects, including dizziness, low sodium, and rare but serious blood or skin reactions. Regular blood tests are often required.

7. Topical lidocaine 5% patch or gel
   Lidocaine patches are approved for postherpetic neuralgia but can sometimes be used off-label for localized neuropathic pain, such as painful areas on the feet in CMT2B5. The patch is applied to the painful skin for a limited number of hours each day as described in the label. Lidocaine numbs the superficial nerves by blocking sodium channels, reducing pain without affecting the whole body. Side effects are usually mild and local, such as skin irritation.

8. Topical capsaicin cream or patches
   Capsaicin is derived from chili peppers and works by overstimulating and then desensitizing specific pain fibers in the skin. High-strength patches are applied in a clinic, while low-strength creams can be used at home under medical guidance. In CMT2B5, capsaicin may help burning pain in small areas like the tops of the feet. It can cause temporary burning or redness at the site, so patients are warned to expect this.

9. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen
   NSAIDs are not specific to nerve pain but help with joint and muscle pain due to altered gait, foot deformities, or overuse. They work by blocking cyclo-oxygenase enzymes and reducing inflammatory prostaglandins. Short courses at the lowest effective dose are usually preferred to limit side effects like stomach upset, kidney strain, and increased bleeding risk. They should be avoided or used carefully in people with kidney, stomach, or heart problems.

10. Paracetamol (acetaminophen)
    Paracetamol is often used as a first-line simple pain reliever for mild aches and pains in CMT2B5. It works centrally in the brain to reduce pain and fever, though its exact mechanism is still not completely clear. When used at recommended doses, it is generally safe, but overdose can cause serious liver injury. It is often combined with other therapies rather than used alone for neuropathic pain.

11. Baclofen (muscle-relaxant for spasticity and cramps)
    Baclofen acts on GABA-B receptors in the spinal cord to reduce muscle overactivity. In some people with CMT2B5, it can help ease painful muscle cramps or stiffness. It is usually started at a low dose several times a day and then slowly increased. Side effects include drowsiness, dizziness, and weakness, so doctors watch carefully for extra falls or fatigue.

12. Tizanidine (alpha-2 agonist for muscle spasticity)
    Tizanidine reduces muscle tone by acting on alpha-2 receptors in the brainstem, decreasing the release of excitatory neurotransmitters. When cramps or stiffness are severe and other drugs are not enough, a neurologist may prescribe it. It is taken several times a day, and side effects can include sleepiness, dry mouth, and low blood pressure, so blood pressure and liver tests are often monitored.

13. Botulinum toxin injections (for selected deformities or spasticity)
    Botulinum toxin can be injected into specific overactive muscles to reduce abnormal pulling and pain. In CMT2B5, it may sometimes be used for painful toe clawing or calf overactivity. The toxin blocks acetylcholine release at the neuromuscular junction, temporarily weakening the muscle for several months. Because it can also weaken needed muscles, injections are done only by experienced specialists.

14. Short-course opioids (for severe acute pain, with great caution)
    In rare situations of severe short-term pain (for example, after surgery), short-acting opioids may be used. They work by binding to opioid receptors in the brain and spinal cord to blunt pain signals. However, because of risks of dependence, tolerance, constipation, and respiratory depression, they are not routine for chronic CMT pain. Doctors try to keep doses low and for the shortest time possible.

15. Selective serotonin reuptake inhibitors (SSRIs) for depression/anxiety
    Chronic pain and disability in CMT2B5 can lead to anxiety or depression. SSRIs, such as sertraline or fluoxetine, are used to treat mood disorders and may indirectly improve pain by improving sleep and coping. They work by increasing serotonin levels in the brain. Side effects may include stomach upset, headaches, and sleep changes. These are chosen when emotional symptoms are a major concern.

16. Hypnotics or melatonin for sleep disturbance (short-term use)
    Pain and cramps often disturb sleep. Short-term use of sleep aids, or melatonin supplements, can help reset sleep patterns. They act on brain pathways that regulate sleep–wake cycles. Doctors aim to use the lowest effective dose for a limited time while also treating the underlying pain and improving sleep hygiene.

17. Antispasmodic agents for gastrointestinal issues
    Some people with chronic neurological conditions develop digestive symptoms due to reduced activity and medicines. Antispasmodic drugs may be used short-term to relieve abdominal cramping, helping people tolerate oral medicines better. They work by relaxing smooth muscles in the gut but can cause dry mouth or constipation, so they must be used carefully.

18. Vitamin D prescription preparations (for documented deficiency)
    When blood tests show low vitamin D, high-dose prescription vitamin D may be given to protect bone health, especially in less mobile people with CMT2B5. Vitamin D helps the gut absorb calcium and supports bone mineralization. The dose and schedule depend on blood levels and are described in the product label; too much can cause high calcium and kidney problems.

19. Bisphosphonates (for severe osteoporosis)
    If long-standing disability leads to osteoporosis and fracture risk, doctors may prescribe bisphosphonates. These drugs slow bone resorption by inhibiting osteoclasts. They are usually taken weekly or monthly with strict instructions to protect the esophagus. They do not change CMT2B5 itself but reduce fracture risk so people can stay active longer.

20. Medications for associated conditions (e.g., diabetes, thyroid disease)
    Sometimes CMT2B5 coexists with other conditions that also affect nerves or muscles. Controlling blood sugar, thyroid levels, or autoimmune disease with standard medicines can prevent extra nerve damage. Good control of these problems indirectly protects the remaining nerve function and may slow worsening of symptoms.

---

Dietary molecular supplements

Evidence for supplements in CMT2B5 is limited, and none are proven cures. The items below are sometimes discussed to support general nerve and muscle health. Always check with a doctor before starting any supplement, especially if you take other medicines.

1. Vitamin B12
   Vitamin B12 is vital for healthy myelin and nerve function. In people with deficiency, replacement can improve nerve conduction and reduce numbness. It is available as oral tablets or injections. In CMT2B5, B12 cannot fix the genetic problem, but correcting deficiency ensures you are not adding a second cause of neuropathy. Too high doses are usually safe but should still be monitored in kidney disease.

2. Vitamin B1 (thiamine) and B6 (pyridoxine) in balanced doses
   B1 and B6 are important in energy production and neurotransmitter metabolism. Balanced B-complex supplements can help if dietary intake is low. Very high doses of B6 can cause neuropathy themselves, so doses should stay within recommended limits. In CMT2B5 they are used mainly as supportive care to optimize metabolic conditions for remaining nerves.

3. Alpha-lipoic acid
   Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. It helps mop up free radicals and may improve nerve blood flow and conduction. For CMT2B5, its use is experimental, and benefits are not well proven. It is usually taken orally once or twice daily. Possible side effects include stomach upset and rare low blood sugar, especially in people with diabetes.

4. Coenzyme Q10 (CoQ10)
   CoQ10 is involved in mitochondrial energy production, which is interesting for GDAP1-related diseases because GDAP1 affects mitochondria. Supplementation may support energy production in nerve and muscle cells, although direct evidence in CMT2B5 is lacking. It is taken in capsule form with food. It is generally well tolerated but can occasionally cause stomach discomfort.

5. Omega-3 fatty acids (fish oil or algae oil)
   Omega-3 fats have anti-inflammatory and cell-membrane-stabilizing effects. They may support cardiovascular health and general nerve health, though specific data in CMT2B5 are limited. Taken as capsules or liquid, they are usually safe, but high doses may increase bleeding tendency, especially with blood-thinning medicines.

6. Vitamin D (maintenance doses)
   Beyond prescription correction of deficiency, maintenance vitamin D in usual daily doses supports bone health and muscle function. This is especially important in people with reduced weight-bearing. Too little vitamin D leads to weak bones, while too much can cause high calcium, so blood tests guide safe dosing.

7. Magnesium (for muscle cramps if deficient)
   Magnesium plays a role in muscle relaxation and nerve transmission. For people with proven low magnesium or frequent cramps, moderate supplementation may help. It is usually taken as tablets at night. Side effects include loose stools at higher doses. It should be used carefully in kidney disease.

8. L-carnitine
   L-carnitine helps transport fatty acids into mitochondria for energy production. Some neuromuscular conditions with mitochondrial dysfunction may benefit when there is deficiency. In CMT2B5, evidence is weak, but some doctors may consider it in selected patients. It is taken orally and is usually well tolerated, though it can cause fishy body odor or stomach upset.

9. Curcumin (turmeric extract)
   Curcumin has anti-inflammatory and antioxidant properties and is being studied in several chronic diseases. In theory, reducing oxidative stress could support nerve health, but solid evidence in CMT2B5 is lacking. Taken with pepper or in formulated capsules, it is better absorbed. It can interact with blood thinners and cause stomach upset at high doses.

10. Probiotic supplements (for gut health and medication tolerance)
    Long-term medications and reduced activity can disturb gut bacteria. Probiotics may help maintain gut balance, improve bowel regularity, and reduce some side effects of medicines. They do not treat CMT2B5 directly but may improve overall well-being and nutrient absorption.

---

Experimental immunity booster and regenerative / stem-cell

At present, there are no approved stem-cell or regenerative drugs for Charcot-Marie-Tooth disease type 2B5. The approaches below are research ideas and clinical-trial topics, not standard treatment. Any dosing is determined only inside formal trials.

1. Gene-replacement therapy targeting GDAP1
   Researchers are exploring gene-therapy vectors (such as AAV) that could carry a healthy GDAP1 gene into nerve cells. The idea is to restore mitochondrial function and prevent further axonal damage. This type of therapy is still in pre-clinical or early clinical stages and is not yet available in routine practice. Safety, delivery to peripheral nerves, and long-term effects are major areas of study.

2. Small molecules that improve mitochondrial function
   Some experimental drugs aim to support mitochondria, for example by enhancing antioxidant defenses or stabilizing mitochondrial membranes. In GDAP1-related disease, these drugs could theoretically reduce stress on nerve cells. At present they are studied mainly in laboratory models and early trials. Any use outside trials is not recommended due to unknown risks.

3. Neurotrophic-factor–based therapies
   Neurotrophic factors like nerve growth factor (NGF) or brain-derived neurotrophic factor (BDNF) support nerve survival and repair. Experimental approaches try to deliver these molecules or stimulate their production in nerves affected by CMT. The challenge is delivering them at the right dose and site without harmful side effects. These therapies remain experimental.

4. Mesenchymal stem-cell therapy
   Mesenchymal stem cells (MSCs) from bone marrow or fat are being studied as possible supports for nerve repair because they can secrete helpful growth factors and modulate inflammation. Some early, small studies in peripheral neuropathy show mixed results. For CMT2B5, robust evidence is lacking, and unregulated stem-cell clinics can be dangerous. Such therapies should only be considered inside registered clinical trials.

5. Induced pluripotent stem cell (iPSC)–based research
   Scientists can turn a patient’s own cells into iPSCs and then make nerve cells in the lab. These patient-specific nerve cells help researchers test drugs and understand disease mechanisms. While this does not directly treat the patient yet, it may lead to targeted medicines in the future by showing which compounds rescue function in GDAP1-mutant cells.

6. Immune-modulating drugs in selected cases
   CMT2B5 itself is not an immune disease, but some patients may also have autoimmune conditions that worsen nerve function. In such cases, doctors may use immune-modulating drugs like IVIG, steroids, or other agents to treat the autoimmune component, not the genetic CMT. This is highly individualized and only considered after specialized evaluation by neuromuscular teams.

---

Surgeries used in Charcot-Marie-Tooth disease type 2B5

1. Tendon transfer surgery for foot drop
   In tendon transfer operations, surgeons move a functioning tendon (such as the posterior tibial tendon) to replace a weak one that lifts the foot. This can help correct foot drop and improve toe clearance during walking. The procedure is usually done when weakness is stable but braces alone are not enough. Recovery involves several weeks of immobilization followed by physiotherapy.

2. Osteotomy (bone-cutting) for cavovarus foot deformity
   CMT2B5 often causes high arches and inward-tilting heels, which lead to instability and pain. An osteotomy reshapes bones in the foot or heel to create a flatter, more balanced foot. This can reduce pain, improve shoe fit, and make walking safer. It is usually considered in adolescents or adults with fixed deformities that cannot be corrected by braces and therapy alone.

3. Joint fusion (arthrodesis) for severe instability or pain
   When joints in the foot or ankle are badly deformed and painful, surgeons may fuse them so they no longer move. This can provide a stable platform for standing and walking and reduce pain, although it sacrifices some flexibility. Fusion is usually a last-line option after other surgeries have failed or are not suitable.

4. Nerve decompression (e.g., tarsal tunnel or carpal tunnel release)
   People with CMT2B5 can also develop compression of nerves in tight tunnels, such as the wrist (carpal tunnel) or ankle (tarsal tunnel). Decompression surgery releases pressure on the nerve by cutting the overlying ligament. This may improve pain, tingling, and numbness due to compression, though it does not change the underlying genetic neuropathy.

5. Spinal surgery for significant scoliosis
   Long-standing muscle imbalance can sometimes lead to curvature of the spine (scoliosis). When scoliosis becomes severe and causes pain or breathing problems, spinal fusion or other corrective procedures may be recommended. These surgeries are major and require careful planning by a multidisciplinary team, including neurologists, orthopedic surgeons, and anesthesiologists familiar with neuromuscular disorders.

---

Prevention and complication-reduction strategies in CMT2B5

1. Avoid known neurotoxic drugs (e.g., certain chemotherapy agents like vincristine) whenever possible, and make sure all doctors know you have CMT.

2. Protect your feet with well-fitting shoes, daily inspection for cuts or blisters, and prompt treatment of any wounds to prevent ulcers and infections.

3. Use braces, walking aids, and home safety changes early to prevent falls and fractures rather than waiting for major accidents.

4. Maintain regular physiotherapy and home exercises to keep joints flexible and muscles active, reducing contractures and deformities.

5. Keep a healthy body weight to reduce stress on weak muscles and joints, improving mobility and lowering pain.

6. Treat other conditions like diabetes, thyroid disease, or vitamin deficiencies quickly to avoid extra nerve damage.

7. Avoid smoking and heavy alcohol use, because they impair circulation and directly damage nerves and muscles.

8. Stay up-to-date with vaccinations, including flu and pneumonia shots, to reduce infections that could lead to weakness and hospitalization.

9. Attend regular follow-up appointments with a neuromuscular specialist, physiotherapist, and podiatrist to catch changes early.

10. Seek mental-health support when needed, because good emotional health supports better self-care and long-term outcomes.

---

What to eat and what to avoid in Charcot-Marie-Tooth disease type 2B5

1. Eat: A balanced diet rich in fruits, vegetables, whole grains, and lean protein to support overall health, energy, and tissue repair.

2. Eat: Foods containing B-vitamins (such as eggs, fish, whole grains, and leafy greens) to support nerve and energy metabolism.

3. Eat: Calcium- and vitamin-D–rich foods like dairy, fortified plant milks, and small fish with bones to keep bones strong when mobility is reduced.

4. Eat: Healthy fats from nuts, seeds, olive oil, and fatty fish to support brain and nerve cell membranes.

5. Eat: Enough fluids and fiber (fruit, vegetables, oats, lentils) to prevent constipation, which can worsen discomfort in less active people.

6. Avoid: Heavy alcohol intake, which can directly damage nerves and worsen balance and weakness.

7. Avoid: Smoking and vaping, which reduce blood flow to nerves and muscles and slow healing.

8. Avoid: Very high-sugar snacks and drinks that promote weight gain and increase risk of diabetes, adding more nerve problems.

9. Avoid: Very salty processed foods that can worsen swelling, blood pressure, and heart strain in less active people.

10. Avoid: Extreme “fad diets” that cut out major food groups and risk vitamin or mineral deficiencies important for nerve health.

---

When to see a doctor for Charcot-Marie-Tooth disease type 2B5

You should see a doctor, ideally a neurologist familiar with neuromuscular diseases, as soon as you notice symptoms such as frequent tripping, foot drop, high arches, thin calves, or persistent numbness and tingling in hands or feet. Early diagnosis allows timely bracing, therapy, and safety planning.

You should also seek medical attention urgently if you have:

• Sudden worsening of weakness, especially if it affects breathing or swallowing.

• New or severe back or neck pain with loss of bladder or bowel control.

• Rapidly increasing pain, redness, or swelling in the feet that could mean infection.

• Very painful cramps, strong new deformities, or frequent falls.

• Mood changes such as hopelessness, severe anxiety, or thoughts of self-harm (tell a trusted adult or doctor immediately).

Regular follow-up, often once or twice a year, is important even when you feel stable, so changes can be recognized early and treatment updated.

---

Frequently asked questions (FAQs)

1. Is Charcot-Marie-Tooth disease type 2B5 curable?
   No. CMT2B5 is a lifelong genetic nerve condition. At present there is no cure or approved medicine that stops the underlying gene problem. Treatment focuses on symptom control, maintaining independence, and preventing complications through therapy, bracing, and careful medical follow-up.

2. Can exercise make CMT2B5 worse?
   Gentle, well-planned exercise usually helps rather than harms. Over-strenuous exercise that causes severe pain or exhaustion should be avoided, but low-impact aerobic activity and supervised strengthening are recommended. A physiotherapist can help design a safe plan for your level of weakness and fatigue. Physiopedia+1

3. Will I end up in a wheelchair?
   Many people with CMT2 forms, including CMT2B5, remain able to walk for many years, especially with early bracing and therapy. Some people may need wheelchairs or scooters for long distances. Needing a device does not mean failure; it is a tool to save energy and prevent falls so you can stay active. Charcot-Marie-Tooth Association+1

4. Can children or teenagers get CMT2B5?
   Yes. GDAP1-related CMT often begins in childhood or adolescence with clumsiness, frequent tripping, or difficulty running. Early assessment by a pediatric neurologist and therapist can help families plan school support, sports choices, and safety measures. PubMed+2research.amanote.com+2

5. Is CMT2B5 always inherited from a parent?
   CMT2B5 is genetic, but sometimes the mutation appears for the first time in the child (a “de novo” mutation). In other families, the mutation is passed down in an autosomal recessive or dominant pattern, depending on the exact GDAP1 change. Genetic counseling can explain the pattern in each family. PubMed+1

6. Can I have a normal life expectancy with CMT2B5?
   Most people with CMT, including many GDAP1-related forms, have a near-normal life span. Health problems are usually related to mobility limits, foot complications, or rarely breathing issues, rather than the nerves themselves directly shortening life. Good care and safety planning greatly improve long-term outlook. Charcot-Marie-Tooth Association+1

7. Does pregnancy make CMT2B5 worse?
   Some women report temporary worsening of symptoms during pregnancy because of weight gain and fluid changes, but many return to baseline afterwards. Planning pregnancy with a neurologist and obstetrician allows careful monitoring, safe delivery planning, and genetic counseling for the baby’s risk.

8. Can CMT2B5 affect my breathing or voice?
   Most people with CMT2B5 do not have major breathing problems, but some GDAP1-related cases have diaphragmatic weakness or vocal-cord involvement. If you notice new shortness of breath, fatigue when lying flat, or hoarseness, you should see a doctor promptly for lung tests and ENT or respiratory review. ScienceDirect+1

9. Are there special medicines I must avoid?
   Certain drugs, such as vincristine and some other chemotherapy agents, are known to worsen neuropathy and should be avoided or used with extreme caution in people with CMT. Always tell every doctor and dentist that you have CMT2B5, and ask them to check for nerve-toxic side effects before prescribing.

10. Is it safe to have surgery and anesthesia with CMT2B5?
    Many people with CMT safely undergo surgeries, including orthopedic procedures. It is important to inform the anesthesiologist about your CMT, breathing status, and any heart or lung issues. They can choose medications and positioning that protect your nerves and breathing as much as possible.

11. Can diet alone treat CMT2B5?
    No food or diet can reverse the genetic nerve damage in CMT2B5. However, a healthy, balanced diet helps maintain weight, bone strength, and overall health, which indirectly supports mobility and daily function. Diet is a helpful support, not a cure.

12. Do braces mean my CMT is very severe?
    Not necessarily. Braces like AFOs are tools to improve safety and reduce fatigue. Using them early often allows people to walk better and stay active longer. They can be adjusted or changed over time as your needs change.

13. Can I play sports if I have CMT2B5?
    Many people with CMT enjoy sports, especially low-impact ones such as swimming and cycling. High-impact or contact sports that risk ankle injuries or falls may be less suitable. A physiotherapist or sports doctor can help choose safe activities and protective equipment.

14. How can my family support me?
    Family members can learn about CMT2B5, encourage safe exercise and brace use, help with home safety changes, and support mental health. Emotional understanding is often as important as physical help. Joining family-friendly CMT groups can help everyone learn and cope together.

15. Where can I learn about new research and trials?
    Reputable CMT organizations, academic neuromuscular centers, and rare-disease registries share up-to-date information about clinical trials, gene therapy studies, and new treatments. Your neurologist or genetic counselor can direct you to trustworthy websites and consider whether any trial is suitable for you. Charcot-Marie-Tooth Association+2PMC+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 29, 2025.